Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394:64–80.
Blanchard P, Lee A, Marguet S, Leclercq J, Ng WT, Ma J, Chan AT, Huang PY, Benhamou E, et al. Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis. Lancet Oncol. 2015;16:645–55.
Yang L, Hong S, Wang Y, Chen H, Liang S, Peng P, Chen Y. Development and External Validation of Nomograms for Predicting Survival in Nasopharyngeal Carcinoma patients after definitive Radiotherapy. Sci Rep. 2015;5:15638.
Article CAS PubMed PubMed Central Google Scholar
Hui EP, Ma BBY, Chan ATC. The emerging data on choice of optimal therapy for locally advanced nasopharyngeal carcinoma. Curr Opin Oncol. 2020;32:187–95.
Lee AW, Ma BB, Ng WT, Chan AT. Management of nasopharyngeal carcinoma: current practice and future perspective. J Clin Oncol. 2015;33:3356–64.
Xiao WW, Huang SM, Han F, Wu SX, Lu LX, Lin CG, Deng XW, Lu TX, Cui NJ, Zhao C. Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: long-term results of a phase 2 study. Cancer. 2011;117:1874–83.
Article CAS PubMed Google Scholar
Zhang Y, Li WF, Mao YP, Zhou GQ, Peng H, Sun Y, Liu Q, Chen L, Ma J. Establishment of an integrated model incorporating standardised uptake value and N-classification for predicting metastasis in nasopharyngeal carcinoma. Oncotarget. 2016;7:13612–20.
Article PubMed PubMed Central Google Scholar
Hui EP, Leung SF, Au JS, Zee B, Tung S, Chua D, Sze WM, Law CK, Leung TW, Chan AT. Lung metastasis alone in nasopharyngeal carcinoma: a relatively favorable prognostic group. A study by the Hong Kong Nasopharyngeal Carcinoma Study Group. Cancer. 2004;101:300–6.
Li JY, Huang CL, Luo WJ, Zhang Y, Tang LL, Peng H, Sun Y, Chen YP, Ma J. An integrated model of the gross tumor volume of cervical lymph nodes and pretreatment plasma Epstein-Barr virus DNA predicts survival of nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a big-data intelligence platform-based analysis. Ther Adv Med Oncol. 2019;11:1758835919877729.
Article CAS PubMed PubMed Central Google Scholar
Zhang J, Teng X, Lam S, Sun J, Cheung AL, Ng SC, Lee FK, Au KH, Yip CW et al. Quantitative spatial characterization of Lymph Node Tumor for N Stage improvement of nasopharyngeal carcinoma patients. Cancers (Basel) 15 (2022).
Chen J, Luo J, He X, Zhu C. Evaluation of contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI) in the detection of Retropharyngeal Lymph Node Metastases in nasopharyngeal carcinoma patients. Cancer Manag Res. 2020;12:1733–9.
Article CAS PubMed PubMed Central Google Scholar
Guan Y, Liu S, Li AC, Pan XB, Liang ZG, Cheng WQ, Zhu XD. A pilot study: N-Staging Assessment of Shear Wave Elastrography in small cervical lymph nodes for nasopharyngeal carcinoma. Front Oncol. 2020;10:520.
Article PubMed PubMed Central Google Scholar
Zhang GY, Liu LZ, Wei WH, Deng YM, Li YZ, Liu XW. Radiologic criteria of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma treated with radiation therapy. Radiology. 2010;255:605–12.
Jin GQ, Yang J, Liu LD, Su DK, Wang DP, Zhao SF, Liao ZL. The diagnostic value of 1.5-T diffusion-weighted MR imaging in detecting 5 to 10 mm metastatic cervical lymph nodes of nasopharyngeal carcinoma. Med (Baltim) 95, e4286 (2016).
Li H, Liu XW, Geng ZJ, Wang DL, Xie CM. Diffusion-weighted imaging to differentiate metastatic from non-metastatic retropharyngeal lymph nodes in nasopharyngeal carcinoma. Dentomaxillofac Radiol. 2015;44:20140126.
Article CAS PubMed Google Scholar
Lydiatt WM, Patel SG, O’Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, Loomis AM, Shah JP. Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67:122–37.
Forghani R, Kelly HR, Curtin HD. Applications of dual-energy computed Tomography for the evaluation of Head and Neck squamous cell carcinoma. Neuroimaging Clin N Am. 2017;27:445–59.
Lam S, Gupta R, Levental M, Yu E, Curtin HD, Forghani R. Optimal virtual monochromatic images for evaluation of normal tissues and Head and Neck Cancer using dual-energy CT. AJNR Am J Neuroradiol. 2015;36:1518–24.
Article CAS PubMed PubMed Central Google Scholar
Forghani R. An update on advanced dual-energy CT for head and neck cancer imaging. Expert Rev Anticancer Ther. 2019;19:633–44.
Article CAS PubMed Google Scholar
Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–47.
Article CAS PubMed Google Scholar
Bossi P, Chan AT, Licitra L, Trama A, Orlandi E, Hui EP, Halamkova J, Mattheis S, Baujat B, et al. Nasopharyngeal carcinoma: ESMO-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up(dagger). Ann Oncol. 2021;32:452–65.
Article CAS PubMed Google Scholar
Gregoire V, Ang K, Budach W, Grau C, Hamoir M, Langendijk JA, Lee A, Le QT, Maingon P, et al. Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiother Oncol. 2014;110:172–81.
Mao YP, Liang SB, Liu LZ, Chen Y, Sun Y, Tang LL, Tian L, Lin AH, Liu MZ, et al. The N staging system in nasopharyngeal carcinoma with radiation therapy oncology group guidelines for lymph node levels based on magnetic resonance imaging. Clin Cancer Res. 2008;14:7497–503.
Article CAS PubMed Google Scholar
Liang SB, Chen LS, Yang XL, Chen DM, Wang DH, Cui CY, Xie CB, Liu LZ, Xu XY. Influence of tumor necrosis on treatment sensitivity and long-term survival in nasopharyngeal carcinoma. Radiother Oncol. 2021;155:219–25.
Article CAS PubMed Google Scholar
Liang SB, Zhang N, Chen DM, Yang XL, Chen BH, Zhao H, Lu RL, Chen Y, Fu LW. Prognostic value of gross tumor regression and plasma Epstein Barr Virus DNA levels at the end of intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma. Radiother Oncol. 2019;132:223–9.
Article CAS PubMed Google Scholar
Zhang Y, Zhang ZC, Li WF, Liu X, Liu Q, Ma J. Prognosis and staging of parotid lymph node metastasis in nasopharyngeal carcinoma: an analysis in 10,126 patients. Oral Oncol. 2019;95:150–6.
Guo SS, Liang YJ, Liu LT, Chen QY, Wen YF, Liu SL, Sun XS, Tang QN, Li XY, et al. Increased angiogenin expression correlates with Radiation Resistance and predicts poor survival for patients with nasopharyngeal carcinoma. Front Pharmacol. 2021;12:627935.
Article CAS PubMed PubMed Central Google Scholar
Hui EP, Li WF, Ma BB, Lam WKJ, Chan KCA, Mo F, Ai QYH, King AD, Wong CH, et al. Integrating postradiotherapy plasma Epstein-Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapy. Ann Oncol. 2020;31:769–79.
Article CAS PubMed Google Scholar
Xue F, Ou D, Hu C, He X. Local regression and control of T1-2 nasopharyngeal carcinoma treated with intensity-modulated radiotherapy. Cancer Med. 2018;7:6010–9.
Article CAS PubMed PubMed Central Google Scholar
Wang G, He L, Yuan C, Huang Y, Liu Z, Liang C. Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma. Eur J Radiol. 2018;98:100–6.
Xiao-ping Y, Jing H, Fei-ping L, Yin H, Qiang L, Lanlan W, Wei W. Intravoxel incoherent motion MRI for predicting early response to induction chemotherapy and chemoradiotherapy in patients with nasopharyngeal carcinoma. J Magn Reson Imaging. 2016;43:1179–90.
Comments (0)